FDA Drug recall D-0744-2023

NORepinephrine added to 0.9% sodium chloride, 8 mg/250 mL* (32 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc.,…

FDA Drug
Class II
terminated
Published 2023-05-31

On 2023-05-31 the FDA classified a Class II recall of NORepinephrine added to 0.9% sodium chloride, 8 mg/250 mL* (32 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc.,… by Central Admixture Pharmacy Services, citing lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Read the official FDA Drug notice

Agency	FDA Drug
Recall number	D-0744-2023
Classification	Class II
Status	terminated
Initiated	2023-04-28
Published	2023-05-31
Last updated	2026-09-13 11:52 UTC
Company	Central Admixture Pharmacy Services
Distribution	US

Product

NORepinephrine added to 0.9% sodium chloride, 8 mg/250 mL* (32 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-8096-1.

Reason

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Identifiers

code_info	Lot # 37-882989, Exp 04/28/2023; 37-883827, 37-883829, 37-883830, 37-883833, 37-883858, Exp 05/02/2023; 37-884758, Exp… Lot # 37-882989, Exp 04/28/2023; 37-883827, 37-883829, 37-883830, 37-883833, 37-883858, Exp 05/02/2023; 37-884758, Exp 05/05/2023; 37-885357, Exp 05/08/2023; 37-885748, 37-885751, Exp 05/09/2023; 37-887409, 37-887410, Exp 05/16/2023; 37-888863, 37-888867, Exp 05/22/2023; 37-889226, Exp 05/23/2023; 37-889576, 37-889577, Exp 05/24/2023; 37-889804, 37-889817, 37-889830, Exp 05/25/2023; 37-891280, Exp 05/31/2023; 37-891758, 37-891759, Exp 06/04/2023; 37-894311, 37-894315, 37-894319, Exp 06/13/2023; 37-895304, Exp 06/18/2023; 37-896544, 37-896545, 37-896546, 37-896552, Exp 06/21/2023; 37-898514, 37-898515, 37-898516, Exp 06/29/2023; 37-899305, Exp 07/03/2023; 37-900362, Exp 07/06/2023

code_info

Lot # 37-882989, Exp 04/28/2023; 37-883827, 37-883829, 37-883830, 37-883833, 37-883858, Exp 05/02/2023; 37-884758, Exp…

Lot # 37-882989, Exp 04/28/2023; 37-883827, 37-883829, 37-883830, 37-883833, 37-883858, Exp 05/02/2023; 37-884758, Exp 05/05/2023; 37-885357, Exp 05/08/2023; 37-885748, 37-885751, Exp 05/09/2023; 37-887409, 37-887410, Exp 05/16/2023; 37-888863, 37-888867, Exp 05/22/2023; 37-889226, Exp 05/23/2023; 37-889576, 37-889577, Exp 05/24/2023; 37-889804, 37-889817, 37-889830, Exp 05/25/2023; 37-891280, Exp 05/31/2023; 37-891758, 37-891759, Exp 06/04/2023; 37-894311, 37-894315, 37-894319, Exp 06/13/2023; 37-895304, Exp 06/18/2023; 37-896544, 37-896545, 37-896546, 37-896552, Exp 06/21/2023; 37-898514, 37-898515, 37-898516, Exp 06/29/2023; 37-899305, Exp 07/03/2023; 37-900362, Exp 07/06/2023

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0744-2023%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.